Danielle Antin-Ozerkis is a Respiratory physician affiliated with Yale University. OpenAlex indexes 61 publications with 3,258 citations (h-index 22); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Howard Ave
Yale Physicians Bldg
New Haven, CT 06520
Telephone
203-785-2140Registry record last updated 28 Jan 2014.
Clinical trials
4 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- Boehringer Ingelheim International GmbHProgram year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.2%Kinase inhibitor23.4%Ofev100%Part D≥23 patientsPurine Antimetabolite9.2%Azathioprine100%Part D<11 patients+ 1 more class in this area
Respiratory
20.7%Corticosteroid16.9%Budesonide-Formoterol Fumarate36%Trelegy Ellipta31%Breo Ellipta21%Symbicort13%Part D<11 patientsbeta2-Adrenergic Agonist3.8%Albuterol Sulfate Hfa100%Part D≥16 patientsAnti-infectives
18.5%Short-acting sulfonamides15.5%Sulfamethoxazole-Trimethoprim100%Part D≥32 patientsPenicillins with extended spectrum3%Amoxicillin-Clavulanate Potass100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”